| Bioactivity | S100P-IN-1 (Compound 4) is a S100P inhibitor with an IC50 of 22.7 nM. S100P-IN-1 shows anti-metastatic effects on pancreatic cancer cells[1]. |
| Target | IC50: 22.7 nM (S100P) |
| Invitro | S100P-IN-1 (Compound 4) blocks S100P binding to RAGE in a dose dependent manner[1].S100P-IN-1 (10 µM, 24 h) shows S100P-specific inhibitory effect on cell invasion, without obvious cytotoxicity[1]. Cell Invasion Assay[1] Cell Line: |
| Name | S100P-IN-1 |
| CAS | 690991-06-1 |
| Formula | C25H16N2O6 |
| Molar Mass | 440.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ramatoulie Camara, et al. Discovery of novel small molecule inhibitors of S100P with in vitro anti-metastatic effects on pancreatic cancer cells. Eur J Med Chem. 2020 Oct 1;203:112621. |
S100P-IN-1
CAS: 690991-06-1 F: C25H16N2O6 W: 440.40
S100P-IN-1 (Compound 4) is a S100P inhibitor with an IC50 of 22.7 nM. S100P-IN-1 shows anti-metastatic effects on pancre
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.